A narrative review on lipid-polymer hybrid nanoparticles for geriatric oncology: advancing drug delivery in the aging population
Open Access
- 6 February 2025
- journal article
- review article
- Published by Wolters Kluwer Health in Aging Advances
- Vol. 2 (1) , 14-20
Abstract
Aging is accompanied by a multitude of physiological changes that significantly impact drug pharmacokinetics and dynamics, posing unique challenges in cancer treatment. Developments in nanotechnology have been crucial to fight against cancer. Lipid polymer hybrid nanoparticles have emerged as a novel nanomedicine platform designed to enhance the efficacy and safety of chemotherapeutic agents, particularly in the aging population. The adoption of nanostructures and their uses in clinical development to enhance and boost the pharmacokinetic and pharmacodynamics characteristics of medicinal substances have also been documented. Liposomes and nanoparticles are extensively utilized in cancer therapy, but are associated with multifaceted drawbacks such as high instability, quick drug release, low biocompatibility, limited drug loading capacity, and unsuitability for large-scale manufacturing. Lipid polymer hybrid nanoparticles, which combine the benefits of lipid- and polymer-based nanocarriers, have been created to get around these restrictions. Additionally, lipid polymer hybrid nanoparticles are now used for combinatorial and active targeted drug delivery, as well as the delivery of genetic materials, diagnostic imaging agents, and vaccines in addition to single drug delivery for anticancer therapy. This narrative review provides an in-depth analysis of the structural elucidation, classification, preparation process, and use of lipid polymer hybrid nanoparticles in cancer treatment and drug delivery in older patients.Keywords
This publication has 73 references indexed in Scilit:
- Magnetic field activated lipid–polymer hybrid nanoparticles for stimuli-responsive drug releaseActa Biomaterialia, 2013
- Nanoparticle-based combination therapy toward overcoming drug resistance in cancerBiochemical Pharmacology, 2012
- Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiformeJournal of Neuro-Oncology, 2010
- Targeting of Nanoparticles: Folate Receptor2010
- PLGA–lecithin–PEG core–shell nanoparticles for controlled drug deliveryBiomaterials, 2009
- Silver nanoparticles immobilized on thin film composite polyamide membrane: characterization, nanofiltration, antifouling propertiesPolymers for Advanced Technologies, 2007
- Nanomedicine: Developing smarter therapeutic and diagnostic modalities☆Advanced Drug Delivery Reviews, 2006
- Micellar Nanocarriers: Pharmaceutical PerspectivesPharmaceutical Research, 2006
- Development of a Respirable, Sustained Release Microcarrier for 5-Fluorouracil I: In Vitro Assessment of Liposomes, Microspheres, and Lipid Coated NanoparticlesJournal of Pharmaceutical Sciences, 2006
- Nanoparticle and targeted systems for cancer therapyAdvanced Drug Delivery Reviews, 2004